Pricing Log in Create free account

Cardinal Health, Inc. (CAH) vs Cellyan Biotechnology Co., Ltd (HKPD)

Cardinal Health, Inc. and Cellyan Biotechnology Co., Ltd are both Medical Distribution companies. Cardinal Health, Inc. is the larger, with a market value of $58.8B against $17.1M — 3433.7× the size. Across the 10 metrics below, Cardinal Health, Inc. leads on 7 and Cellyan Biotechnology Co., Ltd on 3.

Valuation

Metric CAH HKPD Medical Distribution median
P/E 34.99 — —
P/S 0.24 — 0.27
P/B n/m n/m —
Price to free cash flow 13.16 n/m —
EV/EBITDA 17.93 n/m 17.78
EV/Sales 0.25 n/m 0.63
Earnings yield 2.86% — (6.67%)
Free cash flow yield 7.60% 0.00% 0.00%

Profitability

Metric CAH HKPD Medical Distribution median
Gross margin 3.84% — 8.01%
Operating margin 1.03% — 0.46%
Net margin 0.67% — (6.08%)
Free cash flow margin 1.79% 0.00% 0.00%
Return on equity (63.98%) 0.00% 0.00%
Return on assets 3.10% 0.00% 0.00%
Return on invested capital 125.05% 0.00% 0.00%

Growth

Metric CAH HKPD Medical Distribution median
Revenue growth (TTM) 14.23% — 11.54%
EPS growth (last fiscal year) 12.09% (2,492.59%) 5.71%
Revenue growth, 5-year CAGR 9.37% — 8.18%
Net income growth, 5-year CAGR 22.91% 0.00% 0.00%

Health

Metric CAH HKPD Medical Distribution median
Debt to equity (3.26) 0.10 (0.34)
Current ratio 0.88 3.86 1.05
Net debt to EBITDA 1.13 (0.79) (0.01)

Dividend

Metric CAH HKPD Medical Distribution median
Dividend yield 0.81% — —
Payout ratio 0.28 — —

Size

Metric CAH HKPD Medical Distribution median
Market cap 58.75b 17.11m 154.79m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack